Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-004942
Filing Date
2025-11-14
Accepted
2025-11-14 09:01:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9473
2 JOINT FILING AGREEMENT p25-2429exhibit99_1.htm EX-99.1 4183
  Complete submission text file 0000902664-25-004942.txt   15548
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 (650) 457-1978
Structure Therapeutics Inc. (Subject) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93902 | Film No.: 251481642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)